Previous
 
  • Diabetes
  • Diabetes
  • Diabetes
  • Diabetes
Next

LECTURE SCHEDULE R E G I S T E R    N O W  > >


Day 1

Thursday 13th October 2016

 

SESSIONS AND KEYNOTES

08:00 – 08:45

Registration and Exhibition Viewing

08:45 – 09:00

Welcome & Opening Address

Treating "ACCORDingly" - An Evidence-Based Philosophical Approach to Managing Type-2 Diabetes

Dr. Adetokunbo Shitta-Bey, MBBS, MSc, MBA, MRCGP - Consultant Family Physician & Programme Director, Navigating Diabetes Care Conference 2016.

Dr. Shitta-Bey delivers the opening address of the 2016 Navigating Diabetes Care Conference and introduces the central theme of the programme. He considers the lessons learned from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study and its implications for treatment in primary and secondary care. He uses the medium to outline the main objectives of the conference and emphasises the increasingly sub-Saharan profile of this insidious and debilitating global health challenge. 

09:00 – 09:50

Chest Pain (?) Cause! - Ischaemic Heart Disease, Atherosclerosis and "the Diabetic Heart"

Dr. Adeyemi Johnson, MD, FACC - Consultant Physician / Interventional Cardiologist, First Cardiology Consultants, Lagos, Nigeria 

In this session, Dr Johnson considers the nature and state of "the diabetic heart" and explores typical and atypical symptoms presenting within the spectrum of angina and ischaemic heart disease. He examines the correlation between "tight" blood glucose control, coronary artery disease and cardiovascular end-points. He uses this session to discuss the subject of atherosclerosis and outlines practical, evidence-based approaches to management ischaemic symptoms in type 2 diabetic patients. 

09:50 – 10:40

From Metformin to "Gliptins" and "Flozins" - Individualising treatment in type-2 diabetes

Dr. Olufemi Fasanmade, MBBS, FWACP, FACE, FNSEM - Associate Professor / Consultant Physician & Endocrinologist, College of Medicine, University of Lagos (CMUL), Nigeria

In this session, Dr Fasanmade focuses on the range of oral anti-diabetic agents used in the treatment of type 2 diabetes. It discusses internationally recognised guidelines and examines the rationale and supporting evidence underpinning treatment recommendations in each case. He session explores the evolution of type 2 diabetes treatment and highlights advantages and potential pitfalls of new generation DPP-4 and SGLT-2 inhibitors and their place in enhancing optimal diabetes treatment alongside recognised stalwarts of the diabetes "trade" such as Metformin, Sulphonylureas and Glitazones. The session highlights the importance of achieving treatment to target whilst ensuring that care of type 2 diabetic patients is both individualised and delivered within the overall context of cardiovascular risk.

10:40 – 11:00

Coffee & Exhibition Viewing

11:00 – 11:50

Navigating Diabetes Care: Insulin - the final frontier!

Dr. Olufemi Fasanmade, MBBS, FWACP, FACE, FNSEM - Associate Professor / Consultant Physician & Endocrinologist, College of Medicine, University of Lagos (CMUL), Nigeria

Most oral agents used in the treatment of diabetes function either by encouraging production of Insulin or by enhancing its action on peripheral organs and tissues. A grasp of the nature and mode of action of this important peptide hormone produced by pancreatic islet beta cells is fundamental to our understanding of diabetes and effective treatment of this life-threatening condition. Dr Fasanmade considers the central role of Insulin in long-term optimal treatment of type 2 diabetes and presents helpful evidence to support its use at various stages in the care pathway of type 2 diabetic patients. He discusses the various forms and practical applications of this highly essential hormone and examines the precise indications and clinical rationale supporting the use of established regimens in individualised patient treatment plans. 

11:50 – 12:30

Childhood Obesity & Type-2 Diabetes - A Rising Epidemic!

Dr. Ekundayo Ajayi-Obe, MB ChB, FRCPCH - Consultant Paediatrician, Hammersmith Hospital, Imperial College NHS Trust, London, UK

Dr Ajayi-Obe discusses the twin worldwide epidemic of childhood obesity and type-2 Diabetes. She examines the aetiology of the problem and considers its wide-ranging clinical and socio-economic implications for sub-Saharan African society. In this session, Dr Ajayi-Obe will explore important strategies and evidence-based treatment modalities necessary to mitigate the impact of this immediate and long-term public health dilemma.

12:30 – 13:20

Type-2 Diabetes and Cardiovascular Risk - “Diabesity”, Insulin Resistance and the Metabolic Syndrome "X"

Dr. Olufemi Fasanmade, MBBS, FWACP, FACE, FNSEM - Associate Professor / Consultant Physician & Endocrinologist, College of Medicine, University of Lagos (CMUL), Nigeria

Dr Fasanmade examines the related concepts of "Diabesity", Insulin Resistance and the Metabolic "Syndrome X". He discusses the fundamental concept of insulin resistance and considers evidence-based treatment modalities for type 2 Diabetes. In this session, Dr Fasanmade considers the independent component risk factors that make up the metabolic syndrome and explains its relationship with cardiovascular disease and development of type 2 diabetes. 

13:20 – 14:00

Lunch and Exhibition Viewing

14:00 – 15:00

"Reversing Type 2 Diabetes": Metabolic Surgery - Evidence, Efficacy and Risks

Dr. Abuchi Okaro, MS, FRCS, FWACS - Consultant Upper GI & Bariatric Surgeon, Maidstone and Tunbridge Wells NHS Trust, Kent, UK

(Q&A session - Mrs Sherese Ijewere, Nutrition Consultant, Caribbean Health & Nutrition)

Dr. Okaro presents the evidence to support the increasingly central role of weight loss (Bariatric) surgery in achieving remission and potential "cure" in patients with type 2 diabetes. He considers further evidence pointing towards additional significant benefit in a range of other metabolic conditions such as hyperlipidaemia and high blood pressure.

15:00 – 16:30

PANEL DISCUSSION - POLICY & HEALTH SYSTEMS DEVELOPMENT

"Counting the Cost! Healthcare Financing and the Future of Managed Care"

PANEL

Dr Olajide Idris – Honourable Commissioner for Health, Lagos State

Dr Olaokun Soyinka – International Public Health Consultant & Former Commissioner for Health, Ogun State

Dr Leke Oshunniyi – MD/CEO, AIICO Multishield Healthcare

Mrs Clare Omatseye - MD/CEO, JNC International & President, Healthcare Federation of Nigeria

Dr Ayo Shonibare – Consultant Urologist & Transplant Surgeon / CEO, Vantage Medical Centre, Lagos

MODERATOR – Dr A. Shitta-Bey – CEO/Director, Clinical Governance & Education, BeyHealth Consulting LTD.

   

Day 2

Friday 14th October 2016

 

SESSIONS AND KEYNOTES

08:00 – 09:00

Registration and Exhibition Viewing

09:00 – 09:50

Stroke, Metabolic Syndrome and Type 2 Diabetes

Dr. Seyi Roberts, MBBS, FWACP, FMCP - Consultant Physician / Neurologist, Royal Cross Medical Centre, Lagos, Nigeria

Dr. Roberts considers the concept of Stroke as a "brain attack" and discusses primary and secondary prevention of cerebrovascular disaese. He explores the causal relationship between Stroke and type 2 Diabetes and examines treatment options within the context of this sudden and often unexpected life-changing event.

09:50 – 10:40

Diabetes and Hypertension in Pregnancy

Dr. Bosede Afolabi, MBChB, DM (Notts) FRCOG, FWACS, FMCOG - Associate Professor / Consultant Obstetrician & Gynaecologist, College of Medicine, University of Lagos (CMUL), Nigeria

Dr. Afolabi discusses the management of two often related and commonly occurring clinical conditions increasingly prevalent in pregnancy for a variety of clinical and environmental reasons. She examines possible complications arising from the existence of gestational diabetes and hypertensive disease and considers implications for long-term management and further care in subsequent pregnancies. This session highlights relevant evidence underpinning clinical decision-making under these circumstances and provides a framework for assessment and treatment in primary and secondary care. 

10:40 – 11:00

Coffee & Exhibition Viewing

11:00 – 11:50

Statins for All?! - Dyslipidaemia, Risk Reduction and Secondary Prevention of CVD

Dr. Adeyemi Johnson, MD, FACC - Consultant Physician / Interventional Cardiologist, First Cardiology Consultants, Lagos, Nigeria

In this session, Dr. Johnson discusses the broad concept of cardiovascular "risk". He considers the central role of dyslipidaemia within the overall context of cardiac risk and examines the evidence supporting the use of statins and other cholesterol-lowering agents in risk-reduction and secondary prevention of cardiovascular disease.

11:50 – 12:40

Hypertension, Type 2 Diabetes and CKD

Dr. Ebun Bamgboye, MBBS, MD, FWACP - Consultant Physician / Nephrologist, St. Nicholas Hospital, Lagos, Nigeria 

Dr. Bamgboye lays a useful foundation for subsequent sessions on type 2 Diabetes and cardio-renal disease by examining the management of high blood pressure in a variety of clinical circumstances. He provides an overview of hypertensive disease and contextualises evidence-based treatment guidelines relevant to the management of this commonly occuring condition. He focuses eventually on precise implications of high blood pressure in patients with type 2 diabetes and chronic kidney disease (CKD) and discusses treatment guidelines directly applicable to this vast and inherently vulnerable group of patients.  

12:40 – 13:20

Lunch & Exhibition Viewing

13:20 – 14:10

Diabetic Nephropathy & Chronic Kidney Disease - Aetiology, Staging and Treatment

Dr. Ebun Bamgboye, MBBS, MD, FWACP - Consultant Physician / Nephrologist, St. Nicholas Hospital, Lagos, Nigeria

Dr Bamgboye establishes the link between diabetic nephropathy, chronic kidney disease (CKD) and end-stage renal failure (ESRF). He considers the aetiology of these conditions and discusses implications for long-term renal disease and cardiovascular risk. In this session, Dr Bamgboye introduces the subject of microalbuminuria screening and discusses its implications for staging and treatment of these conditions. He examines the central role of angiotensin converting enzyme and receptor blocking (ACE / ARB) agents in reno-protection and overall reduction in cardiovascular risk and goes further to explore evidence-based criteria and international classification systems for diabetic nephropathy and chronic kidney disease in a variety of clinical settings.

14:10 – 14:50

Type 2 Diabetes and Eye Disease - Focus on Diabetic Retinopathy

Dr. Ogugua Okonkwo, MD, FRCS(Edin), FWACS - Consultant Ophthalmic Surgeon & Vitreoretinal Specialist, Eye Foundation Centre for the Prevention of Blindness, Lagos, Nigeria

Retinopathy is the most common ocular manifestation of type 2 diabetes. In this session, Dr Okonkwo discusses the aetiology and effects of this insidious and sight-threatening microvascular complication, and examines the correlation between diabetic retinopathy, nephropathy and long-term glucose control. He outlines the benefits of retinopathy screening in effective treatment and care of type 2 diabetic patients and sets out the evidence to support the use of screening as an integral part of a periodic diabetic review.

14:50 – 15:40

Renal Replacement Therapy & Transplantation (1): Dialysis - Indications, Management and Implications for long-term Care

Dr. Ebun Bamgboye, MBBS, MD, FWACP - Consultant Physician / Nephrologist, St. Nicholas Hospital, Lagos, Nigeria

Dr. Bamgboye kicks off the first in a highly insightful (three-part) series of combined lectures with Dr. Ayo Shonibare focused on the subject of End Stage Renal Failure (ESRF). He discusses indications, management and long-term implications of established kidney failure and dialysis, and lays the foundation for further detailed discussion in relation to kidney transplantation surgery. 

15:40 – 16:30

Renal Replacement Therapy & Transplantation (2): Kidney Transplantation Surgery – Indications, Management and Implications for long-term care

Dr. Ayo Shonibare, MB BCh, FRCS, FWACS - Consultant Urologist & Kidney Transplant Surgeon, Vantage Medical Centre, Lagos, Nigeria

Dr. Shonibare delivers the second in this series of lectures on "Renal Replacement Therapy and Transplantation". He focuses attention on kidney transplantation surgery and explores relevant indications, possible complications, management and implications for long term care of patients. He illustrates relevant issues further by way of a selection of case presentations grounded in local context.

16:30 – 16:45

Renal Replacement therapy & Transplantation (3): Kidney Transplantation in Nigeria – A selection of case studies

Dr. Ayo Shonibare, MB BCh, FRCS, FWACS - Consultant Urologist & Kidney Transplant Surgeon, Vantage Medical Centre, Lagos, Nigeria

This session is the third in the series on "Renal Replacement Therapy and Transplantation". Dr. Shonibare illustrates the (renal) end of the cardio-renal spectrum by means of a selection of personal case studies highlighting the challenges and complexities of renal transplantation locally.

16:45 – 16:50

Thanks & Acknowledgements

16:50

End of Programme